Psychedelic neuroscience /

"We are in the midst of what is being called the 'psychedelic renaissance' with growing interest into how psychedelics alter consciousness, brain function and brain connectivity. The acute, often profound, effects of the psychedelic experience can induce lasting improvements in mental...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Calvey, Tanya (Επιμελητής έκδοσης)
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cambridge, MA : Academic Press is an imprint of Elsevier, 2018.
Έκδοση:First edition.
Σειρά:Progress in brain research ; v. 242.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04229nam a2200577 4500
001 on1076269083
003 OCoLC
005 20200326101157.0
006 m o d
007 cr |||||||||||
008 181126s2018 maua ob 000 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d MMU  |d OCLCO  |d N$T  |d OPELS  |d OCLCA  |d YDX  |d TFH  |d OCLCO  |d CNCGM  |d UKMGB  |d OCLCF  |d OCLCO  |d BRX  |d DKU  |d OCLCO  |d VT2  |d AU@  |d OCLCO  |d OCLCQ  |d UKAHL  |d OCLCA  |d GrThAP 
015 |a GBB8N1788  |2 bnb 
015 |a GBB8M8933  |2 bnb 
016 7 |a 019144406  |2 Uk 
016 7 |a 019160268  |2 Uk 
019 |a 1076428634  |a 1091238722 
020 |a 9780128142561  |q (electronic bk.) 
020 |a 0128142561  |q (electronic bk.) 
020 |a 9780128142554  |q (hardcover) 
020 |a 0128142553  |q (hardcover) 
035 |a (OCoLC)1076269083  |z (OCoLC)1076428634  |z (OCoLC)1091238722 
050 4 |a RM324.8 
060 4 |a QV 77.7 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a PSAN  |2 bicssc 
082 0 4 |a 615.7883  |2 23 
245 0 0 |a Psychedelic neuroscience /  |c edited by Tanya Calvey. 
250 |a First edition. 
264 1 |a Cambridge, MA :  |b Academic Press is an imprint of Elsevier,  |c 2018. 
300 |a 1 online resource (vi, 257 pages) :  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Progress in brain research,  |x 0079-6123 ;  |v volume 242 
504 |a Includes bibliographical references. 
505 0 |a An introduction to psychedelic neuroscience / Tanya Calvey and Fleur M. Howells -- The renaissance in psychedelic research: what do preclinical models have to offer / Kevin S. Murnane -- D-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: mechanism of action and potential therapeutic applications in mood disorders / Danilo De Gregorio, Justine P. Enns, Nicolas A. Nuñez, Luca Posa and Gabriella Gobbi -- Common neural signatures of psychedelics: frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition / Selen Atasoy, Jakub Vohryzek, Gustavo Deco, Robin L. Carhart-Harris and Morten L. Kringelbach -- A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder / Joseph Barsuglia, Martin Polanco, Robert Palmer, Benjamin Malcolm, Benjamin Kelmendi and Tanya Calvey -- Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: contributions of the resting brain / Felix Müller, Matthias E. Liechti, Undine E. Lang and Stefan Borgwardt -- Neurocognitive effects of cannabis: lessons learned from human experimental studies / Marco Colizzi and Sagnik Bhattacharyya -- Ibogaine as a treatment for substance misuse: potential benefits and practical dangers / John Martin Corkery. 
520 |a "We are in the midst of what is being called the 'psychedelic renaissance' with growing interest into how psychedelics alter consciousness, brain function and brain connectivity. The acute, often profound, effects of the psychedelic experience can induce lasting improvements in mental health demonstrating that chemistry forms the basis of mystical experience, consciousness and mental wellbeing"--Publisher's description. 
588 0 |a Online resource; title from electronic title page (ScienceDirect, viewed November 27, 2018). 
650 0 |a Hallucinogenic drugs. 
650 1 2 |a Hallucinogens.  |0 (DNLM)D006213 
650 1 2 |a Brain  |x drug effects.  |0 (DNLM)D001921Q000187 
650 2 2 |a Hallucinogens  |x therapeutic use.  |0 (DNLM)D006213Q000627 
650 2 2 |a Psychopharmacology  |x methods.  |0 (DNLM)D011600Q000379 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Hallucinogenic drugs.  |2 fast  |0 (OCoLC)fst00950651 
655 4 |a Electronic books. 
700 1 |a Calvey, Tanya,  |e editor. 
776 0 8 |i Print version:  |t Psychedelic neuroscience.  |b First edition.  |d Cambridge, MA : Academic Press is an imprint of Elsevier, 2018  |z 0128142553  |z 9780128142554  |w (OCoLC)1047795790 
830 0 |a Progress in brain research ;  |v v. 242.  |x 0079-6123 
856 4 0 |3 ScienceDirect  |u https://www.sciencedirect.com/science/bookseries/00796123/242  |z Full Text via HEAL-Link